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Background. Patients with end-stage renal disease (ESRD)
are at increased risk of cardiovascular mortality and morbid-
ity. Many complications arise in ESRD patients as a result of
the twin arterial pathologies of atherosclerosis and arterioscle-
rosis. Part of this latter process is calcification of the arterial
media, which is thought significantly to increase vascular stiff-
ness. The aim of our study was to explore the relationship
between measures of arterial stiffness—pulse wave velocity
(PWV)—and the extent of calcification in the coronary arteries
(CAC).
Methods. Over a period of 2 years 82 patients from our renal
unit were invited to participate in our study. Sixty-two patients
agreed to undergo electron beam computerized tomography
(EBCT), and in 55 (38 males and 17 females), PWV measure-
ments were made. EBCT and PWV measurements were done
according to previously described protocols.
Results. The mean age of the 55 patients was 56.4 years. The
mean duration of dialysis was 65.4 months, and the mean CAC
score was 2551. The mean PWV was 9.13 m/s. PWV strongly
correlated with total CAC even after correction for age, dialysis
duration, and time averaged C-reactive protein (CRP) (P =
0.0001). CAC scores were significantly different when compared
according to PWV tertiles (P = 0.0001).
Conclusion. We have demonstrated that PWV is strongly re-
lated to the degree of EBCT-derived coronary artery calcium
score in chronic kidney disease patients.
Patients with end-stage renal disease (ESRD) are at
increased risk of cardiovascular mortality and morbid-
ity. Clinical and epidemiologic studies have shown that
structural and functional changes in conduit arteries are
a major contributing factor to the high mortality in ure-
mic patients. Macrovascular complications caused by
atherosclerosis are increased in prevalence and speed of
Key words: coronary artery calcification, pulse wave velocity, arterial
stiffness.
Received for publication August 1, 2003
and in revised form September 15, 2003
Accepted for publication November 21, 2003
C© 2004 by the International Society of Nephrology
onset in ESRD patients. These are partly responsible for
the high incidence of ischemic heart disease, congestive
heart failure, sudden death, and stroke [1]. Of equal or
greater importance, however, are arteriosclerosis and ar-
terial stiffening [2], because they are prime determinants
of left ventricular hypertrophy and patient survival on
dialysis [3].
Reasons behind increased arterial stiffness in ESRD
are not fully understood, but it is believed that vascu-
lar (medial) calcification is a major contributing factor.
Guerin et al, using a semiquantitative assessment based
on a B-mode ultrasound-derived score calculated accord-
ing to the number of arterial sites with calcifications,
demonstrated in ESRD patients that the presence of mu-
ral vascular calcifications in large arteries of hemodial-
ysis patients was associated with increased pulse wave
velocity (PWV) (arterial stiffness) [4]. Subsequently, the
same group demonstrated prospectively that both the in-
creased arterial stiffness [5] and the presence of large-
artery calcification [6] were major predictors of all-cause
and cardiovascular mortality in chronic kidney disease
patients.
Only recently, with techniques such as electron-beam
computerized tomography (EBCT), has it been possible
to accurately and quantitatively assess coronary artery
calcification (CAC).
In the general population, such CAC scores are
strongly predictive of coronary artery atherosclerosis and
of future major adverse cardiac events [7]. The phe-
nomenon of CAC has been much reported in ESRD pa-
tients over the last 7 years. It has increased enormously
in dialysis patients [8], and also appears at a younger age
[9] and progresses rapidly [10]. However, unlike arterial
stiffness, its prognostic significance in ESRD remains to
be determined.
In order to explore potential implications of CAC
we studied the relationship between direct measures
of large-artery stiffness with prognostic value in ESRD
patients (aortic PWV) and coronary artery calcifica-
tion measured with a reproducible and accurate method
(EBCT) [11, 12].
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Table 1. Patient characteristics
N Valid Mean SE mean Median SD Minimum Maximum
Age years 55
Weight kg 55 68.7 1.8 66 13.3 39 103
Dialysis duration months 48 65.4 12.8 24 88.8 1 372
Aortic PWV m/s 55 9.1 .2 9 1.5 5.9 12.3
CAC total score 55 2551.1 373.8 1640 2772.5 0 11538
Time-averaged CRP mg/L 55 19.6 3.3 12 23.8 1 151
Albumin g/L 55 34.9 .5 35 4.0 27 43
Cholesterol mmol/L 55 4.8 .2 5 1.1 2 8
Time-averaged calcium mmol/L 55 2.4 0 2 .1 2.2 2.7
Time-averaged phosphorus mmol/L 55 1.6 0 1 .3 1.0 2.5
Calcium-phosphorus ion product mmol2/L2 55 3.7 .1 4 .8 2.25 5.52
SBP mm Hg 55 145.4 3.9 142 28.9 90 219
DBP mm Hg 55 73.9 1.8 70 13.1 50 104
Pulse pressure mm Hg 55 71.3 3.1 67 23.0 40 123
Abbreviations are: PWV, pulse wave velocity; CAC, coronary artery calcification; CRP, C-reactive protein; SBP, systolic blood pressure; DBP, diastolic blood pressure.
METHODS
Study subjects
Over a period of 2 years (May 2001 to May 2003),
82 patients from our renal unit were invited to partici-
pate in a study trying to find a relation between PWV
and EBCT-generated CAC. Sixty-two patients agreed to
undergo EBCT, and of these, 55 (38 males and 17 fe-
males) underwent measurement of aortic PWV within 3
months of EBCT. Only these 55 patients’ results have
been analyzed. All of the studied patients had renal
impairment—26 were on hemodialysis, 4 on continu-
ous ambulatory peritoneal dialysis, 7 had chronic kid-
ney disease not requiring dialysis, and 18 were postrenal
transplantation.
The causes of renal failure in the 55 patients were
glomerulonephritis in 18, diabetes in 17, Alport’s syn-
drome in 9, renovascular disease in 3, polycystic kidney
disease in 4, and reflux nephropathy and hypertension
each in 2 patients.
A database was constructed including baseline demo-
graphic and laboratory data from the information on the
Renal Unit computer database for each patient. These
included height and weight at the time of EBCT, sys-
tolic and diastolic blood pressure, time-averaged systolic
and diastolic BP values (average of all the blood pressure
readings of the patients during their follow-up period),
the duration of chronic renal disease; mean levels for
calcium, phosphorus, calcium-phosphorus product, albu-
min, total nonfasting cholesterol and C-reactive protein
(CRP) were derived from 12 to 84 months of routine bio-
chemical information for all 55 patients (see Table 1). The
median number of blood test values for each patient was
49 (range 12 to 396). A complete dataset was compiled for
each patient. Medication charts for the preceding (1 to 8)
years on dialysis were reviewed to calculate the daily dose
of calcium-containing phosphate binder, and the total cu-
mulative exposure to calcium-containing oral phosphate
binders.
Protocol of electron-beam CT
All subjects underwent electron-beam computed to-
mography (CT) at the Imatron Unit, Royal Brompton
Hospital, on a C-100 scanner (Imatron; South San Fran-
cisco, CA, USA) [11]. Images were performed with 100-
ms scanning time, and a single slice thickness of 3-mm.
Thirty-six to 40 tomographic slices were obtained for each
subject during two breath-holding sessions. Tomographic
imaging was electronically triggered at 40% of the R-R
interval to minimize cardiac movement, and proceeded
from the carina to the diaphragm. The intra-assay coeffi-
cient of variation for the scoring was <5%.
The acquired images were scored with the use of Ima-
tron software by a single radiologist blinded to the clinical
or angiographic history of the patient. As originally de-
scribed by Agatston [11], the degree of coronary artery
calcification was calculated by multiplying the area of
each calcified lesion by a weighting factor correspond-
ing to the peak pixel intensity for each lesion to yield a
lesion-specific calcification score. The sum of the scores
of all arterial lesions was used for analysis.
Pulse wave velocity protocol
A carotid and a femoral artery waveform were ob-
tained consecutively using the SphygmoCor apparatus
(PWV, Inc., Westmead, Australia) and customized soft-
ware. Using an ECG gated signal and anthropometric
distances, the PWV was derived using methodology pre-
viously described and validated [13, 14].
The intraobserver error for PWV was determined in
20 young healthy volunteers (−3.5%); in 10 dialysis
patients (−4.7%); and in 10 renal transplant patients
similarly studied (−3.8%). When the intraobserver re-
producibility was assessed with a 4-hour gap between
readings, at rest, and without dialysis or hemodynamic
drugs, the intra-observer error was 5.8% [14]. All the
measurements were made by a single operator.
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Fig. 1. Scatter plot of pulse wave velocity (PWV) and coronary artery calcification (CAC) score.
Statistical analysis
All values are expressed as mean ± standard error
unless stated in the text. Spearman’s rho correlation (non-
parametric) coefficient was used for bivariate correla-
tion calculations. Bivariate partial correlations were used
to correct for possible confounders. A multiple linear
regression analysis was also used to examine associa-
tions between PWV and CAC adjusted for possible con-
founders. The square root transform of CAC score was
used to normalize the data. Comparisons between groups
were made using the Mann-Whitney test. Kruskal-Wallis
test was used to compare more than two not normally
distributed means. A P value of < 0.05 was considered to
be statistically significant.
RESULTS
Patient characteristics
Baseline characteristics of the patients are outlined in
Table 1. The mean age of the 55 patients was 56.4 ± 14.1
(SD) years (range 21 to 80). There were 17 females and
38 males. The mean duration of dialysis was 65.4 months
(median 24, range 1 to 372), and the mean CAC score was
2551 ± 373.8 (median 1640, range 0 to 11,538). The mean
PWV was 9.13 ± 0.19 m/s (median 8.9, range 5.9 to 12.3).
Pulse wave velocity correlations (Spearman’s rho)
Pulse wave velocity strongly correlated with total CAC
(P = 0.0001 r = 0.65) (see Fig. 1). PWV also positively
correlated with patient age (P = 0.0001, r = 0.592), dial-
ysis duration (P = 0.037, r = 0.303), and time-averaged
CRP (P = 0.028, r = 0.301), but not with time-averaged
plasma phosphate, plasma calcium, calcium-phosphorus
ion product levels, or with the total cumulative exposure
to calcium-containing oral phosphate binders. PWV was
slightly higher in men than women (mean 9.37 and mean
8.56, respectively, P = 0.06). Pulse wave velocity was not
associated with systolic blood pressure, but was inversely
associated with diastolic pressure (P = 0.005, r = −0.37).
CAC was also inversely associated with DBP in this pop-
ulation (r = −0.44, P = 0.0007).
It is well known that both vascular stiffness and CAC
increase with age and duration of dialysis [3, 15] and in-
flammation [16], and they also vary with sex and dias-
tolic BP. The age- and sex-adjusted partial correlation
between CAC and PWV was r = 0.46. Further adjust-
ment for dialysis duration, time-averaged CRP, and dias-
tolic blood pressure reduced this to a partial correlation
(r = 0.31). In a multiple linear regression analysis PWV
was significantly associated with CAC (P = 0.001), and
remained so on adjusting for age, sex, dialysis duration,
time-averaged CRP, and diastolic blood pressure (P =
0.03). Mode of dialysis and transplantation status had no
impact on measured PWV.
Coronary artery calcifications and pulse wave
velocity tertiles
To further dissect the relationship between in-
creased coronary artery calcification scores and increased
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Fig. 2. Bar chart showing pulse wave velocity (PWV) tertiles and coro-
nary artery calcification (CAC) scores.
aortic stiffness, we divided the study population into
PWV tertiles. The first tertile (PWV range 5.9 to 8.35) had
a mean CAC of 853, the second tertile (PWV range 8.36
to 9.4) had a mean CAC of 1975, and the third group had a
mean CAC of 4858 (PWV range 9.41 to 12.3) (see Fig. 2).
Comparison of the three means using Kruskal-Wallis
test showed a statistically significant difference with P =
0.0001. Intermeans comparison (Mann-Whitney U test)
again showed a statistically significant difference with a
P value of 0.001 for the comparison of the first and sec-
ond tertiles, and of 0.03 for the second and third tertiles
comparison (see Fig. 2).
DISCUSSION
The result of our study demonstrated for the first
time that increased arterial stiffening—measured as aor-
tic PWV—is independently predictive of EBCT-derived
CAC score in chronic kidney disease (CKD) patients. We
demonstrated a close correlation between CAC and PWV
(r = 0.65), even after correcting for confounders like age
and dialysis duration, which might increase aortic stiff-
ness [3]. We found that CAC strongly correlated with the
tertiles of PWV, so that as PWV increased, CAC also in-
creased proportionally (P = 0.0001).
We provide strong evidence to link conduit artery
functional characteristics with the extent of accurately
determined vascular calcification. This relationship was
apparent after correcting for patient characteristics rec-
ognized as influencing both the calcification process and
PWV: age, duration of dialysis, inflammation, and the pre-
scribed dose of calcium-based phosphate binders [17].
The present findings are important because arterial calci-
fication may be the only known preventable factor in the
vicious circle of arterial stiffness/increased PWV in CKD
patients.
Vascular abnormalities (structural and functional)—
an almost invariable ESRD complication—have recently
emerged as the most powerful predictors of a negative
outcome in CKD populations. Three factors that have
a complex inter-relationship include: arterial stiffness
(elastic incremental modulus of the carotid artery), in-
creased aortic PWV, and vascular (conduit artery) cal-
cification. It has been demonstrated that total mortality
increased by 39% with every 1 m/s increase in PWV [17,
18], 1.9 times an increase in all-cause mortality hazard
ratio for each unit increment in calcification [6], and 1.6
times an increase in all-cause mortality for each standard
deviation increase in carotid artery elastic modulus [6].
Although a link between vascular stiffness and calcifi-
cation is suspected, the few previous studies in the litera-
ture correlating arterial stiffness with calcification have
used (at best) semiquantitative B-mode ultrasound or
plain x-ray imaging [6] of the aorta and large muscular-
elastic arteries (carotid, femoral); neither of these two
imaging techniques is optimal to detect and quantify vas-
cular calcification. The most accurate and reproducible
vascular calcification detection and quantification tech-
niques involve CT scanning (most notably, EBCT scan-
ning to derive a CAC score)[11, 12].
In the general population there is a complex relation-
ship between BP and arterial stiffness. Increased SBP,
reduced DBP, and widened pulse pressure are all asso-
ciated with increasing arterial stiffness [14]. Important
however, in this study the correlation between CAC and
PWV was independent of BP after multivariate analy-
sis. This strengthens the likely association between vessel
structure and function.
The greatly increased CAC and its early onset and rapid
progression [9] in dialysis, though remarkable, has an un-
certain significance. Our study directly links this easily
defined cardiac parameter with a validated, prognosti-
cally important functional vessel characteristic (PWV).
Previous studies have shown a tight correlation between
the degree of coronary and aortic calcifications, and that
they are closely linked also in terms of risk factors for
progression [10, 19]. Furthermore, a new avenue is open
to exploration: it is possible that the increased aortic stiff-
ness places a higher burden on the coronary endothelium
(higher endothelial stress), initiating a process of accel-
erated atherosclerosis and calcification at this level that
will translate into higher rates of ischemic heart disease
compared with nonrenal subjects.
Limitations of this study include case-mix and renal re-
placement therapy-mix diversity, small patient numbers,
and a large spread of patient dialysis exposures. In or-
der to ensure generalizability of these data, larger, single
cohort (dialysis, transplanted) studies are required.
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CONCLUSION
We now need a study, population-based or interven-
tional, which is empowered to provide useful prognostic
information that can address the progression or retarda-
tion of coronary and aortic calcification, and vessel func-
tional changes in uremic subjects.
Reprint requests to Dr. David J.A. Goldsmith, MA FRCP, Guy’s Hos-
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